PAREA @pareascience.bsky.social retweeted
The @PsyPal_EU project was recently highlighted at the Hopkins-Oxford Psychedelic Ethics (HOPE) Summit in Washington, D.C, and represented by Tadeusz Hawrot of @PareaScience. Read more about the event here: palliativeprojects.eu/psypal…
PAREA @pareascience.bsky.social retweeted
Replying to @Drug_Science
@Drug_science @PareaScience @MindMedicineAU position statement regarding the forthcoming @US_FDA hearing of @MAPS MDMA submission #MDMA4PTSD drugscience.org.uk/allaying-…
PAREA @pareascience.bsky.social retweeted
You'll be interested to read a short article analysing the recent FDA Advisory Committee’s views against MDMA therapy. This article is a joint publication by @Drug_Science, @PareaScience and @MindMedicineAU. Read more: buff.ly/45G853b #psychedelics #fda #mdma
PAREA @pareascience.bsky.social retweeted
Replying to @Drug_Science
@Drug_Science @PareaScience @MindMedicineAU together publish their critique of the recent FDA AdCom negative opinion on MDMA as a medicine - how to make sense of a flawed analysis ttps://www.drugscience.org.uk/doubt-it-not-mdma-is-a-medicine
PAREA @pareascience.bsky.social retweeted
Join us and other co-organizers of Paths @norrsken_org @PareaScience @Psyched_Alpha @blossomact to uncover why access to these transformative treatments is a pressing issue. This event is free to prepare for the groundbreaking discussions at the summit!
open-foundation.org/events/o…
PAREA @pareascience.bsky.social retweeted
In a watershed moment for psychedelics in Europe, the European Medicines Agency held a workshop to discuss regulatory guidelines for the development and therapeutic use of #PsychedelicMedicines.
👇
@EMA_News @PareaScience @psychglobal_
#MentalHealth
psychedelichealth.co.uk/2024…
PAREA @pareascience.bsky.social retweeted
.@PareaScience PAREA has launched a policy paper in line with a recent meeting on #Psychedelics in the European Parliament.
The paper calls for several changes to innovate mental healthcare in #Europe.
Find out more. 👇
psychedelichealth.co.uk/2023…
PAREA @pareascience.bsky.social retweeted
Replying to @PareaScience
@PareaScience founder Tadeusz Hawrot provided insights into the unmet needs in #MentalHealth conditions as #Europeans spiral into mental health crisis that remains underresearched & lacks medical innovation. #PsychedelicTherapies have potential to revolutionise mental healthcare. – at Brussels, Belgium
PAREA @pareascience.bsky.social retweeted
Psychedelics are hot in the field of mental health! So many people are here to learn more about the latest science on therapeutical #psychedelics.
#ECNP2023 @deedsou @DaniloDeGregor1 @N_Gukasyan
PAREA @pareascience.bsky.social retweeted
🧠 Study results suggest improved efficacy of DMT therapy with SSRIs
🔎 Transcend Therapeutics receives $1 m grant with Yale University
🇨🇦 Canada approves first legal medical psilocybin access
Read more in Issue 149 of The Psychedelics Newsletter: psych.global/psych_weekly/is…
PAREA @pareascience.bsky.social retweeted
.@PareaScience has launched a manifesto for the 2024 EU elections which sets out priorities for the EU as it looks towards the potential rollout of #PsychedelicTherapy in the future.
Find out more. 👇
#Europe #Health #Policy
psychedelichealth.co.uk/2023…
PAREA @pareascience.bsky.social retweeted
Really challenging and interesting topical debate #EFIC2023 on New research approaches and trial design with controversial drugs for pain management by @TimPnin hype/expectation &placebo @DavidFinn14 Cannabis/cannabinoids and @jamesbclose psychedelic assisted therapy
PAREA @pareascience.bsky.social retweeted
In a new policy briefing for the EMA, @PareaScience has called for an advisory body on #Psychedelics to be established in #Europe.
Find out more. 👇
#HealthInnovation #MentalHealth
psychedelichealth.co.uk/2023…
PAREA @pareascience.bsky.social retweeted
At #PSYCHSymposium: London 2023, a panel of change-makers and MEPs discussed the current outlook for #PsychedelicMedicine in Europe, how far the needle has moved and which actions are needed to bring about an evolution in approach. ⬇️
youtu.be/v5znsRVLC0U?si=G5Db…
PAREA @pareascience.bsky.social retweeted
How cost effective is psychedelic therapy as a healthcare treatment? 🤔
In this epsiode of our podcast, Prof David Nutt speaks with Tadeusz Hawrot and Frédéric Destrebecq from PAREA Science, the EU multistakeholder alliance. @pareascience
Listen now!👂
drugscience.org.uk/podcast/8…
PAREA @pareascience.bsky.social retweeted
In response to the EU's "once-in-a-generation" Pharmaceutical Package revision, @PareaScience is calling for #Psychedelics to be at the forefront of #MentalHealth innovation.
Find out more. 👇
#PsychedelicResearch #Europe
psychedelichealth.co.uk/2023…
PAREA @pareascience.bsky.social retweeted
⏰ New podcast episode ⏰ Prof David Nutt catches up with Tadeusz Hawrot and Frédéric Destrebecq from PAREA about the latest developments in research and clinical development with psychedelics in Europe. 🇪🇺
Listen now! 👂
@PAREAscience @profdavidnutt
drugscience.org.uk/podcast/8…
PAREA @pareascience.bsky.social retweeted
In a groundbreaking milestone for #Psychedelics in Europe, a cross-party MEP Action Group for the Medical Use of Psychedelics has launched.
Find out about the key aims of the group. 👇
@PareaScience @PsychedelicsEU
#Europe #HealthInnovation
psychedelichealth.co.uk/2023…
PAREA @pareascience.bsky.social retweeted
European Parliament members met on Wednesday at their headquarters in France and established a new group dedicated to advancing the field of clinical psychedelics in Europe.
#psychedelics #Europe
mugglehead.com/european-parl…
















